Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...

A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the ...

The intended therapeutic effect of gonadotropin-releasing-hormone (GnRH) agonists is hypogonadism, which is a leading cause of osteoporosis in men. Observations are consistent with this effect ...

Advanced prostate cancer is cancer that has spread beyond the prostate to distant parts of the body. It is also called ...

Sep. 4, 2024 — A treatment paradox has recently come to light in prostate cancer: blocking testosterone production halts tumor growth in early disease, while elevating the hormone can delay ...

A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.

Prostate cancer is a health issue that impacts individuals worldwide, and choosing the best treatment can be difficult, given ...

Orion's collaboration partner Bayer has submitted an application to the Center of Drug Evaluation (CDE) of China's National ...

Advanced imaging reveals hidden metastases in high-risk prostate cancer cases, offering new insights for better diagnosis and treatment strategies.

Prostate cancer hijacks the normal prostate's growth ... less commonly, cryosurgery; hormonal therapy and chemotherapy are generally reserved for cases of advanced disease (although hormonal ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

Prostate cancer cells rely on testosterone to help them grow. Hormone therapy, a treatment to stop your body from producing testosterone, is often used to shrink advanced prostate cancer and slow ...